MOVING HIGH PERFORMANCE FIBERS FORWARD CARBON FIBER CARBON FIBER DATA Standard Modulus Property UOM Value Breaking Tenacity g/d 23.0 Specific Gravity Ratio 1.80 Elongation @ Break % 1.5 Tensile Modulus g/d 1480 Moisture Regain* % 0 Creep** % 0 Shrinkage*** % 0 Melt Point °C None Decomposition Temp.

ECCOH™ LOW SMOKE AND FUME, NON-HALOGEN FORMULATIONS PRODUCT SELECTION GUIDE ECCOH™ Low Smoke and Fume, Non-Halogen Solutions *Dry Silane abbreviated as DS **Cross-linked using Sioplas method 5549 UV Teck-90 5700 5801 UV 5865 5982 UV 6010 6151 6638 UV XLS 8001 APPLICATION Type Jacket Jacket Jacket Jacket Jacket Jacket Insulation Tight buffer, Micro-tube Jacket Jacket CABLE Type LV, Data LV LV, Data, OFC LV, Data, OFC Data, OFC LV, OFC LV OFC Data, OFC LV MARKETS Type B & C, Industrial Industrial, Teck-90 B & C, Industrial Industrial, Oil & Gas, Shipboard B & C B & C, Industrial Automotive B & C, Industrial B & C, Industrial B & C, Shipboard Cross-linked No No No Yes No No Yes No No Yes Cross-linking Method* N/A N/A N/A DS/E-beam N/A N/A DS/E-beam N/A N/A Sioplas GENERAL PROPERTIES Properties as Thermoset x x x SG g/cm³ 1.59 1.54 1.60 1.50 1.57 1.52 1.38 1.46 1.48 1.48 MFI, 150°C/21.6 Kg g/10 min 2.8 5 6 3.5 4 5.9 4.4 6 3 6 Hardness Shore D 44 54 50 46 50 54 56 53 53 49 Tensile psi 1740 2610 1595 1800 1740 2320 3336 2466 2030 2030 Elongation % 160% 200% 136% 133% 180% 150% 145% 160% 175% 160% LOI % 45% 36% 51% 39% 45% 41% 30% 33% 42% 33% Low temp brittleness (LTB) °C -26.5°C -49°C -10.5°C -30°C -39°C -38.5°C -41°C -35.5°C -26 -40.5 Max.

Abrasion Resistance Ultraviolet (UV) Resistance Flame Resistance Chemical Resistance (Acid Chemical Resistance (Alkali) Chemical Resistance (Organic Solvent) Strength Retention (H2O) P X P P P P P Property UOM Value Breaking Tenacity g/d 28 Specific Gravity Ratio 1.39 Elongation @ Break % 4.6 Tensile Modulus g/d 590 Moisture Regain* % 2.0 Creep** % < 1.5 Shrinkage*** % < 0.1 Melt Point °C N/A Decomposition Temp.

Recycle Loop AAnchor Mg/kg Anthranilamide Mg/kg Virgin

Hanna consolidate • Cultures clash – commodity wins • Dependent on income derived from commodity joint ventures The First 6 Years • Globally organized along three strategic platforms • Non-core equity investment dispositions • Talent upgrades, discipline instilled throughout organization • New CEO hired to transform POL into specialty business �18 of 20 officers new • Implemented four pillar strategy • Nearly 50% of The Second 6 Years History of PolyOne – A Transformation • Focused on increasing volume, not profits • Heavily tied to cyclical markets 2000 2006 2012 The FormationThe Formation The TransformationThe Transformation The New PolyOneThe New PolyOne organization • Demonstrated ability to deliver • Nearly 50% of business operating income derived from Specialty Platform* • Specialty assets acquired *Pro forma for ColorMatrix acquisition Page 8 30% 50% 70% 90% $10 $12 $14 $16 $18 PolyOnePolyOne Stock Price S&P 500 (relative performance) Strategy and Execution Drive Results | | | | -50% -30% -10% 10% 30% $0 $2 $4 $6 $8 $10 2006 2007 2008 2009 2010 2011 2012 Page 9 Four Pillar Strategy The World’s Premier Provider of Specialized Polymer Materials, Services & Solutions Page 10 60% 80% 100% % o f O p e ra ti n g I n co m e * Old PolyOne Transformation 2012 Target “What We Said” Mix Shift Highlights Specialty Transformation Ahead of Schedule *Operating Income excludes Corporate Charges ** Pro Forma for the acquisition of ColorMatrix and divestiture of SunBelt 2% 34% 42% 50% >50% 0% 20% 40% 2005 2008 2011 2011** 2012 % o f O p e ra ti n g I n co m e * JV's PP&S Distribution Specialty Specialty OI $5M $46M $89M $117M “What We Said” Page 11 2007 2012 Target 2011 “Where we were” “What we said” “Where we are” 1) Operating Income % Specialty 3.2% 10% - 12% 8.9% PP&S 6.1% 8% - 10% 7.2% Pro forma ColorMatrix Proof of Performance Distribution 3.0% 4% - 5% 5.6% 2) Specialty Platform sss% of Operating Income 20% >50% 50% 3) Specialty Vitality Index 21% 35% - 40% 49% 4) ROIC* (pre-tax) 11% >15% 16% 5) Sales outside the US 37% >40% 40% *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Page 12 2011 Pro forma ColorMatrix 2015 Target “Where we are” “Where we expect to be” 1) Operating Income % Specialty 8.9% PP&S 7.2% 12 – 16% 9 – 12% Elevating our Expectations and Yours PP&S 7.2% Distribution 5.6% 2) Specialty Platform % of Operating Income 50% 3) ROIC* (after-tax) 10% 4) Adjusted Annual EPS Growth 3 yr CAGR = 71% 9 – 12% 6 – 7.5% 65 – 75% 15% Double Digit Expansion *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Page 13 • Four pillar strategy, coupled with our ability to execute is driving results • Strong leadership team driving growth & executing • Innovation and services provide differentiation and How do we get there?

D is t. ) K W R R P M P P G A V Y F U L G C P H X L F M C F O E IF F H U N E C L A S H E M N K R A C E S C L G R A A LB Median: 5%Median: 3% Source: Peer data per Bloomberg market data as of June 4, 2021 Avient reflects 2021 estimated revenue of $4,300M and excludes one-time synergy capture CAPEX ($20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators. Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA Median: 84% Median: 78% HIGH FREE CASH FLOW CONVERSION Avient reflects 2021 estimated EBITDA of $560M and excludes one-time synergy capture CAPEX ($20M) Source: Peer data per Bloomberg market data as of June 4, 2021 87 89 87 86 83 81 76 88 85 83 82 81 80 78 78 78 76 72 71 69 50 18 A vi en t K W R P P G R P M A V Y F U L G C P F M C H X L U N V R IF F E C L A S H F O E C E E M N B N R H U N G R A K R A S C L A L B Source: Peer data per Bloomberg market data as of June 4, 2021 Total Enterprise Value / 2021E EBITDA Our current valuation with updated guidance implies an EBITDA multiple that is below specialty formulator peers and the majority of our chemical peers. With the Clariant Masterbatch acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 28 Avient reflects 2021 estimated EBITDA of $560M OUR VALUATION VERSUS PEERS Avient Specialty Formulators Other Chemical/Specialty Companies 10.4 18.2 16.0 15.5 15.3 11.3 11.0 29.7 26.5 23.5 18.2 13.4 11.9 11.9 11.7 10.5 10.4 10.3 10.1 9.7 7.7 6.5 A vi en t K W R A V Y P P G R P M F U L G C P H X L A L B E C L IF F F M C B N R A S H G R A E M N F O E S C L U N V R C E K R A H U N Median: 11.7xMedian: 15.4x SUMMARY: WHY INVEST IN AVIENT?

These injection moldable TPEs can be overmolded to polypropylene (PP) and come in a natural grade that can be easily colored.

Renewable resources on the other hand replenish naturally, and can reduce pollution, mitigate climate change, and support better health outcomes for humans.

Renewable resources on the other hand replenish naturally, and can reduce pollution, mitigate climate change, and support better health outcomes for humans.

These injection moldable TPEs can be overmolded to polypropylene (PP) and come in a natural grade that can be easily colored.